perfluoropentane: Clinical Trials

3 trials of perfluoropentane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 available, 1 completed, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1

Follow perfluoropentane: new trials by email Literature Review of perfluoropentane trials Research Report on perfluoropentane

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress
dodecafluoropentane (0.025 mL/kg), dodecafluoropentane (0.032 mL/kg), dodecafluoropentane (0.050 mL/kg) - Mild Respiratory Distress
Phase 1RecruitingNuvOx LLC182025-03-132026-01-28
The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma
NVX-108 - Glioblastoma Multiforme
Phase 1CompletedNuvOx LLC112014-05-012019-02-28
NuvOx Expanded Access
NanO₂ - Glioblastoma, Respiratory Distress Syndrom
AvailableNuvOx LLC2026-08-05

Conditions studied

Glioblastoma (2)  ·  Dyspnea (1)  ·  Ischemic Stroke (1)

Sponsors

NuvOx LLC (3)

Countries

Australia (1)  ·  Canada (1)

Top investigators

Jason Lickliter, MBBSPhDFRACP (1)

Results publications

PMID 37609003